Covid Vaccine: developing serum in India,

1. Vaccine developing serum in India.

It is worth mentioning that Oxford is making AstraZeneca vaccine in India as a serum institute. The Serum Institute claims that the company has produced around 50 million doses of the vaccine. Serum is confident that the Indian government may soon allow emergency use of the Covid vaccine. According to Adar Poonawala, CEO of Serum Institute of India, the company will produce around 300 million doses by July 2023. Not only this, by the end of the new year 2023, there are preparations to make 300 million doses.

China Vaccine Effective 79.34%

A subsidiary of China’s state-run drug maker Sinpharma said on Wednesday that its corona vaccine is 79.34 percent effective. It has requested the Chinese government to give regulatory approval to the vaccine. If this happens, it will be the first time that China will approve a corona vaccine for public use. Vaccine effects have been assessed on the basis of Phase III trials. The special thing is that on December 9, the United Arab Emirates had said about this vaccine that it is 86 percent effective.